Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (Simplex)
  • No Skin
Collapse
Cobens Direct
  1. Home
  2. Investments and Portfolios
  3. Trump and RFK vs Pharma

Trump and RFK vs Pharma

Scheduled Pinned Locked Moved Investments and Portfolios
3 Posts 2 Posters 49 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • C Offline
    C Offline
    Cappo
    wrote on last edited by
    #1

    Just wondering what funds (if any) might be clobbered by the appointment of “we don’t need vaccines” RFK? I caught the tail end of a comment earlier that some related funds had dropped by 3% overnight?

    (I’m trying very hard to avoid commenting on the IQ and mindset of both appointer and appointee!)

    1 Reply Last reply
    0
    • A Offline
      A Offline
      Adam Kay
      Global Moderator
      wrote on last edited by
      #2

      Hi Cappo,
      Pfizer, Sanofi, Astra Zeneca, Zoetis, Bristol Myers Squibb were the beneficiaries. We don't hold them directly-perhaps some tiny passive. I was looking at Pfizer just this week. Once at $60, now sub $25. Not due to CV vaccines though, well i suppose some but it has an issue with patent expiration-a patent cliff edge on a lot of big drugs (Eliquis, Inlyta, Prevnar, Ibrance) and others. 25% of its revenue is at risk from generics. So perhaps not cheap enough. A nice big dividend (6.5%) to lure you in but will get chopped if/when income falls.

      Heres what I think in regards your question. The market will overreact to something like this. Would Kennedy stop all vaccines? Are pharma companies making big money from same at the moment have prices already adjusted (Covid over)? I wouldn't recommend buying any company/businesss due to one product and what impact would he have?

      Tough business drug companies. Billions to develop a winner. Many failures. Block buster therapies make lots of money but when their patent expires they are worth little.

      Pfizer has 85k employees and revenue of 60B. 4,5B earnings. Mkt Cap 145B
      Vertex has 5.5K employees and revenue of 11B, earnings $4B. Mkt Cap 125B

      1 Reply Last reply
      1
      • C Offline
        C Offline
        Cappo
        wrote on last edited by
        #3

        Hi Adam, hope all good with you. Interesting stuff above in your post, thanks, I’ve learnt a little bit there!

        1 Reply Last reply
        0
        Reply
        • Reply as topic
        Log in to reply
        • Oldest to Newest
        • Newest to Oldest
        • Most Votes


        The value of your investments can go down as well as up, and you may get back less than you invested.

        Cobens a trading name of Astute Financial Management UK Limited is authorised and regulated by the Financial Conduct Authority. Registered Address: 4th Floor Peek House, 20 Eastcheap, London, EC3M 1EB. Registered in England and Wales No. 5850981.

        • Login

        • Don't have an account? Register

        • Login or register to search.
        • First post
          Last post
        0
        • Categories
        • Recent
        • Tags
        • Popular
        • Users
        • Groups